GONIX | VMNIX | GONIX / VMNIX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 11 years | 26 years | - |
Gain YTD | 1.782 | 1.438 | 124% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 100000 | 5000000 | 2% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 99M | 431M | 23% |
Annual Yield % from dividends | 0.00 | 4.92 | - |
Returns for 1 year | 13.51 | 1.51 | 898% |
Returns for 3 years | 38.10 | 25.20 | 151% |
Returns for 5 years | 43.37 | 42.05 | 103% |
Returns for 10 years | 31.73 | 25.32 | 125% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BKMC | 106.83 | 1.17 | +1.11% |
BNY Mellon US Mid Cap Core Equity ETF | |||
XPH | 45.76 | 0.29 | +0.64% |
SPDR® S&P Pharmaceuticals ETF | |||
TOTL | 39.70 | 0.03 | +0.08% |
SPDR® DoubleLine® Total Return Tact ETF | |||
BFIX | 24.78 | -0.04 | -0.16% |
Build Bond Innovation ETF | |||
NVDS | 25.90 | -0.25 | -0.96% |
Tradr 1.5X Short NVDA Daily ETF |